单B细胞两步筛选在7天内获得3株磷酸三苯酯(TPHP)兔单抗,建立侧向层析免疫分析
A Rabbit Monoclonal Antibody-Based Lateral Flow Immunoassay for Triphenyl Phosphate Enabled by Single-B-Cell-Based Two-Step Screening
Analytical Chemistry 发表的一项研究采用单B细胞两步筛选,在7天内获得3株抗TPHP兔单抗,icELISA的IC50为0.021–0.055 ng/mL。
- 背景
- 磷酸三苯酯(TPHP)是新兴的有机磷酸酯类污染物,原文将其与不良健康效应相关联。目前,针对 TPHP 的免疫分析快速筛查方法仍然缺失;兔单克隆抗体(RmAbs)虽然被视为小分子免疫分析的理想识别元件,但高效获得小分子特异性 RmAbs 的路径仍然有限。因此,这项工作要同时解决两个问题:建立一条能稳定产出小分子特异性兔单抗的筛选流程,并把抗体做成可现场使用的 TPHP 检测方法。难点集中在筛选环节:一方面,先把半抗原特异性 B 细胞富集出来;另一方面,还要判断所得抗体识别的究竟是游离的 TPHP 本身,还是偶联在其他结构上的半抗原。
- 做法
- 作者提出单 B 细胞两步筛选策略(SCTS)。第一步用双荧光激活细胞分选(dual FACS)富集半抗原特异性 B 细胞;第二步用 icELISA 筛选培养上清,挑出能够识别游离 TPHP 的抗体克隆。原文给出的时间跨度是:从细胞分选到功能验证在 7 天内完成。按这一流程共获得三株兔单抗,随后与本研究内评估的小鼠单抗做比较,比较两者的灵敏度、特异性,以及对热、pH、离子强度、乙腈的耐受性。为解释亲和力差异,作者对 RmAb3B11 做分子对接,考察其 CDR-H3 与结合腔的形态。检测端以 RmAb3B11 为识别元件搭建侧流免疫分析(LFIA):在河水、粉尘、生奶与包装奶四类基质中测定可视化检出限,并用 40 份盲样与 UPLC−MS/MS 结果比对。
- 结论
- 三株 RmAb 的 icELISA 半抑制浓度(IC50)为 0.021−0.055 ng/mL。与本研究评估的小鼠单抗相比,这些兔单抗的灵敏度与特异性更高,对热、pH、离子强度、乙腈的耐受性也更强。基于 RmAb3B11 的 LFIA 可视化检出限为:河水 0.2 ng/mL、粉尘 1.0 ng/g、生奶与包装奶 0.8 ng/mL。在 40 份盲样中,LFIA 与 UPLC−MS/MS 结果一致性良好,作者据此认为方法的准确性与可靠性得到支持。把两组数字并列可以看出,抗体在 icELISA 中的 IC50 已到 0.021−0.055 ng/mL,而试纸条的可视化判定落在 0.2−1.0 ng/mL(或 ng/g)量级,抗体层面的亲和力优势在层析体系中被现场可读性折损了一部分。
- 机制
- 分子对接结果提示,RmAb3B11 的性能提升可能与其延长的 CDR-H3 有关:该环区形成了更深、约束更强的结合腔,形状互补性更高,对 TPHP 的空间区分也更严格。原文用的是“可能相关”的措辞,这是计算对接给出的结构性解释,并非实验验证的因果链,也没有用突变体回补数据支撑。对热、pH、离子强度与乙腈的耐受性优势,原文未给出机制层面的说明。
- 意义
- 这项工作的落点有两个。方法学上,它给出一条从分选到功能验证 7 天内完成的小分子兔单抗生成路径,并把“识别游离小分子”作为第二步筛选的判据写进流程,这是单 B 细胞路线用于半抗原时容易卡住的环节。应用上,RmAb3B11 支撑的 LFIA 覆盖河水、粉尘与奶类三类实际基质,配合 40 份盲样的比对结果,为 TPHP 的现场快速筛查提供了可用的抗体与试纸条方案。原文对 TPHP 免疫分析“尚不可得”的判断,正是这套方案要对标的位置。
原文摘要
出版方登记 · CrossrefTriphenyl phosphate (TPHP) is an emerging organophosphate ester contaminant associated with adverse health effects, yet immunoassay-based methods for its rapid screening remain unavailable. Rabbit monoclonal antibodies (RmAbs) are attractive recognition elements for small-molecule immunoassays, but efficient strategies for generating small-molecule-specific RmAbs are still limited. Here, we developed a single-B-cell-based two-step screening (SCTS) strategy to generate RmAbs against TPHP. The workflow combined dual fluorescence-activated cell sorting for enrichment of hapten−specific B cells with icELISA-based screening of culture supernatants to identify antibodies recognizing free TPHP. From cell sorting to functional validation, the process was completed within 7 days. Using this strategy, three RmAbs were obtained, with icELISA half-maximal inhibitory concentration (IC50) values of 0.021−0.055 ng/mL. Compared with the mouse monoclonal antibodies evaluated in this study, the RmAbs exhibited higher sensitivity and specificity, together with greater tolerance to heat, pH, ionic strength, and acetonitrile. Molecular docking suggested that the improved performance may be associated with the extended CDR-H3 of RmAb3B11, which formed a deeper and more restrictive binding cavity with higher shape complementarity and stronger steric discrimination toward TPHP. Based on RmAb3B11, a lateral flow immunoassay (LFIA) was established for rapid on-site detection of TPHP, with visual detection limits of 0.2 ng/mL in river water, 1.0 ng/g in dust, and 0.8 ng/mL in raw and packaged milk. Analysis of 40 blind samples showed good agreement between LFIA and UPLC−MS/MS results, supporting the accuracy and reliability of the method.
页面未能读取全文,以上为出版方登记的摘要;方法与图表见原文
本页是 AI 精读,不转载论文原文;完整论文(含方法、图表与参考文献)见原文
来源:Analytical Chemistry · doi.org